OCON Therapeutics Secures $10M Investment to Advanced 3D Drug Delivery Solutions for Women
Israeli-based pioneer of intrauterine drug-delivery technology for treating severe uterine conditions, OCON Therapeutics, has secured $10m in funding to revolutionize drug delivery capabilities.
Led by CEO Keren Leshem, the company’s latest funding round was spearheaded by RH Capital, with a significant contribution from Features Capital, Exerte Partners- Family Office , and Astia Angels.
Read More: htt... moreOCON Therapeutics Secures $10M Investment to Advanced 3D Drug Delivery Solutions for Women
Israeli-based pioneer of intrauterine drug-delivery technology for treating severe uterine conditions, OCON Therapeutics, has secured $10m in funding to revolutionize drug delivery capabilities.
Led by CEO Keren Leshem, the company’s latest funding round was spearheaded by RH Capital, with a significant contribution from Features Capital, Exerte Partners- Family Office , and Astia Angels.
